Bioregenx (BRGX) Net Cash Flow (2022 - 2026)
Bioregenx (BRGX) recorded quarterly Net Cash Flow of -$23577.0 in Q1 2026, down 205.09% quarter-over-quarter from $22436.0 in Q4 2025, and down 186.43% on a YoY basis from $27280.0 in Q1 2025.
Bioregenx (BRGX) Net Cash Flow (2022 - 2026) Analysis & Trends
Bioregenx's Net Cash Flow history runs 5 years deep, the most recent figure standing at -$23577.0 for Q1 2026.
- In Q1 2026, Net Cash Flow fell 186.43% year-over-year to -$23577.0; the TTM figure through Mar 2026 stood at -$37844.0 (down 24.45% YoY), while the FY2025 annual figure was $13013.0, up 118.6% from the prior year.
- Net Cash Flow was -$23577.0 for Q1 2026 at Bioregenx, down from $22436.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $68381.0 in Q4 2023 to a low of -$239056.0 in Q2 2023.
- Historically, Net Cash Flow has averaged -$36135.5 across 5 years, with a median of -$12285.0 in 2024.
- Biggest YoY gain for Net Cash Flow was 8005.32% in 2023; the steepest drop was 28655.33% in 2023.
- A 5-year view of Net Cash Flow shows it stood at -$865.0 in 2022, then jumped by 8005.32% to $68381.0 in 2023, then sank by 122.89% to -$15653.0 in 2024, then soared by 243.33% to $22436.0 in 2025, then tumbled by 205.09% to -$23577.0 in 2026.
- The last three Net Cash Flow figures came in at -$23577.0 (Q1 2026), $22436.0 (Q4 2025), and -$6731.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 475.88 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 800.32 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | -53.56 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -21.68 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 16.39 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 154.34 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | -14.11 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -60.16 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 41.02 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | -23,577.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23,577.00 |
| Mar 31, 2026 | -23,577.00 |
| Dec 31, 2025 | 22,436.00 |
| Dec 31, 2025 | 22,436.00 |
| Sep 30, 2025 | -6,731.00 |
| Sep 30, 2025 | -6,731.00 |
| Jun 30, 2025 | -29,972.00 |
| Jun 30, 2025 | -29,972.00 |
| Mar 31, 2025 | 27,280.00 |
| Mar 31, 2025 | 27,280.00 |
| Dec 31, 2024 | -15,653.00 |
| Dec 31, 2024 | -15,653.00 |
| Sep 30, 2024 | 15,246.00 |
| Sep 30, 2024 | 15,246.00 |
| Jun 30, 2024 | -57,282.00 |
| Jun 30, 2024 | -57,282.00 |
| Mar 31, 2024 | -12,285.00 |
| Mar 31, 2024 | -12,285.00 |
| Dec 31, 2023 | 68,381.00 |
| Dec 31, 2023 | 68,381.00 |